Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03345095 |
|---|---|
| Brief Title: | A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma (MIRAGE) |
| First Submitted : | November 7, 2017 |
| First Submitted that Met QC Criteria : | November 14, 2017 |
| First Posted : | November 17, 2017 |
| Last Update Submitted that Met QC Criteria : | June 29, 2020 |
| Last Update Posted : | July 1, 2020 |